13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000884300
Total reported value
$127.2M
$127.2M
91 檔
31.3%
During the Q4 2025 filing period, Perkins Capital Management Inc (CIK: 0000884300) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $127.2M across 91 reported positions.
Perkins Capital Management Inc executed strategic sector rebalancing during Q4 2025, establishing 8 new positions while fully exiting 1 holdings and trimming 27 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | Stock-Healthcare | 8.10% | +0.37% | -0.67% | |
| 2 | LLY | Eli Lilly & Co | Stock-Healthcare | 7.65% | +0.58% | -1.38% | |
| 3 | AXGN | Axogen Inc | Stock-Other | 5.93% | +0.13% | -3.27% | |
| 4 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 5.21% | -1.09% | — | |
| 5 | MSFT | Microsoft CORP | Stock-Tech | 4.69% | -0.68% | -0.24% | |
| 6 | ✓ | Mdxhealth SA | Stock-Other | 3.91% | -2.72% | -1.69% | |
| 7 | AMD | Advanced Micro Devices | Stock-Tech | 3.00% | +3.39% | -4.08% | |
| 8 | ATEC | Alphatec Holdings Inc | Stock-Other | 2.87% | -0.56% | -0.91% | |
| 9 | BFLY | Butterfly Network Inc | Stock-Other | 2.79% | +2.23% | -0.05% | |
| 10 | VCYT | Veracyte Inc | Stock-Other | 2.52% | +0.50% | -5.33% | |
| 11 | ABT | Abbott Laboratories | Stock-Healthcare | 2.13% | -0.54% | -0.70% | |
| 12 | SKYT | Skywater Technology Inc | Stock-Other | 1.93% | -0.35% | -21.41% | |
| 13 | LMAT | Lemaitre Vascular Inc | Stock-Other | 1.86% | -0.73% | -5.12% | |
| 14 | OOMA | Ooma Inc | Stock-Other | 1.70% | +0.21% | -2.78% | |
| 15 | ONDS | Ondas Inc | Stock-Tech | 1.57% | -0.40% | -1.07% | |
| 16 | MGNI | Magnite Inc | Stock-Other | 1.57% | +0.14% | -7.24% | |
| 17 | CYRX | Cryoport Inc | Stock-Other | 1.56% | +0.89% | -1.58% | |
| 18 | PSNL | Personalis Inc | Stock-Other | 1.51% | +1.09% | -5.35% | |
| 19 | APPS | Digital Turbine Inc | Stock-Other | 1.45% | — | -5.18% | |
| 20 | NEO | Neogenomics Inc | Stock-Healthcare | 1.32% | +0.34% | +3.65% | |
| 21 | QUIK | Quicklogic CORP | Stock-Other | 1.32% | +1.35% | +34.52% | |
| 22 | OWLT | Owlet Inc | Stock-Other | 1.31% | -0.03% | — | |
| 23 | TELA | Tela Bio Inc | Stock-Other | 1.31% | -0.01% | +67.57% | |
| 24 | CIEN | Ciena CORP | Stock-Tech | 1.17% | -0.80% | -32.98% | |
| 25 | INGN | Inogen Inc | Stock-Other | 1.16% | -1.16% | EXIT | |
| 26 | INUV | Inuvo Inc | Stock-Other | 1.15% | -0.62% | -12.77% | |
| 27 | ABBV | Abbvie Inc | Stock-Healthcare | 1.06% | -0.04% | — | |
| 28 | PERI | Perion Network Ltd. | Stock-Other | 1.05% | -0.21% | +12.55% | |
| 29 | BLZE | Backblaze Inc-a | Stock-Other | 1.03% | +2.75% | -0.45% | |
| 30 | AAPL | Apple Inc | Stock-Tech | 1.00% | -0.03% | — | |
| 31 | CXDO | Crexendo Inc | Stock-Other | 1.00% | +0.12% | +15.40% | |
| 32 | NEOG | Neogen CORP | Stock-Healthcare | 0.99% | -0.30% | — | |
| 33 | LUCD | Lucid Diagnostics Inc | Stock-Other | 0.97% | -0.26% | -0.09% | |
| 34 | VELO | Velo3d Inc | Stock-Other | 0.95% | — | +24.29% | |
| 35 | ZETA | Zeta Global Holdings Corp-a | Stock-Tech | 0.91% | +0.04% | -1.74% | |
| 36 | ✓ | Stock-Other | 0.89% | -1.07% | EXIT | ||
| 37 | CSTL | Castle Biosciences Inc | Stock-Other | 0.87% | -0.05% | -0.36% | |
| 38 | ATRC | Atricure Inc | Stock-Other | 0.86% | -0.31% | -1.08% | |
| 39 | GILD | Gilead Sciences Inc | Stock-Healthcare | 0.81% | -0.22% | — | |
| 40 | USIO | Usio Inc | Stock-Other | 0.76% | +0.62% | -17.74% | |
| 41 | PFE | Pfizer Inc | Stock-Healthcare | 0.74% | -0.30% | -4.36% | |
| 42 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.73% | -0.11% | — | |
| 43 | PROF | Profound Medical CORP | Stock-Other | 0.71% | -0.09% | — | |
| 44 | CDXS | Codexis Inc | Stock-Other | 0.69% | +0.13% | +72.08% | |
| 45 | VERI | Veritone Inc | Stock-Other | 0.65% | -0.29% | EXIT | |
| 46 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.62% | — | +2.13% | |
| 47 | VTRS | Viatris Inc | Stock-Healthcare | 0.57% | -0.03% | +0.35% | |
| 48 | USB | US Bancorp | Stock-Financials | 0.53% | -0.02% | -2.71% | |
| 49 | ANIP | Ani Pharmaceuticals Inc | Stock-Other | 0.53% | -0.57% | EXIT | |
| 50 | CELC | Celcuity Inc | Stock-Other | 0.51% | -0.21% | -18.99% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AXGN | Axogen Inc | +2.2% | -3.27% | Trim |
| 2 | NTRA | Natera Inc | +1.7% | -0.67% | Trim |
| 3 | LLY | Eli Lilly & Co | +1.5% | -1.38% | Trim |
| 4 | BFLY | Butterfly Network Inc | +1.2% | -0.05% | Trim |
| 5 | VELO | Velo3d Inc | +0.8% | +24.29% | Add |
| 6 | ATEC | Alphatec Holdings Inc | +0.7% | -0.91% | Trim |
| 7 | NEO | Neogenomics Inc | +0.4% | +3.65% | Add |
| 8 | AMD | Advanced Micro Devices | +0.4% | -4.08% | Trim |
| 9 | CSTL | Castle Biosciences Inc | +0.3% | -0.36% | Trim |
| 10 | QUIK | Quicklogic CORP | +0.2% | +34.52% | Add |
| 11 | TELA | Tela Bio Inc | +0.2% | +67.57% | Add |
| 12 | ONDS | Ondas Inc | +0.2% | -1.07% | Trim |
| 13 | CELC | Celcuity Inc | +0.2% | -18.99% | Trim |
| 14 | VCYT | Veracyte Inc | +0.1% | -5.33% | Trim |
| 15 | DAWNGBX | Day One Biopharmaceuticals I | +0.1% | +2.13% | Add |
| 16 | APYX | Apyx Medical CORP | +0.1% | +4.94% | Add |
| 17 | MRK | Merck & Co. Inc. | +0.1% | — | Unchanged |
| 18 | VTRS | Viatris Inc | +0.1% | +0.35% | Add |
| 19 | PSNL | Personalis Inc | +0.1% | -5.35% | Trim |
| 20 | CXDO | Crexendo Inc | 0% | +15.40% | Add |
| 21 | CDXS | Codexis Inc | 0% | +72.08% | Add |
| 22 | PERI | Perion Network Ltd. | 0% | +12.55% | Add |
| 23 | IDXX | Idexx Laboratories Inc | -0.3% | — | Unchanged |
| 24 | ✓ | -0.3% | +0.34% | Add | |
| 25 | T | At&t Inc | -0.3% | -20.64% | Trim |
| 26 | LFVN | Lifevantage CORP | -0.3% | -0.07% | Trim |
| 27 | INGN | Inogen Inc | -0.3% | +7.32% | Add |
| 28 | USIO | Usio Inc | -0.3% | -17.74% | Trim |
| 29 | ABT | Abbott Laboratories | -0.4% | -0.70% | Trim |
| 30 | ELUT | Elutia Inc | -0.5% | -31.01% | Trim |
| 31 | HAIN | Hain Celestial Group Inc | -0.5% | -60.86% | Trim |
| 32 | LMAT | Lemaitre Vascular Inc | -0.5% | -5.12% | Trim |
| 33 | OPRX | Optimizerx CORP | -0.5% | -53.70% | Trim |
| 34 | APPS | Digital Turbine Inc | -0.7% | -5.18% | Trim |
| 35 | SKYT | Skywater Technology Inc | -0.9% | -21.41% | Trim |
| 36 | MSFT | Microsoft CORP | -0.9% | -0.24% | Trim |
| 37 | INUV | Inuvo Inc | -0.9% | -12.77% | Trim |
| 38 | MGNI | Magnite Inc | -1% | -7.24% | Trim |
| 39 | BLZE | Backblaze Inc-a | -1.3% | -0.45% | Trim |
| 40 | BKSY | Blacksky Technology Inc | -1.7% | -75.79% | Trim |
| 41 | ✓ | Mdxhealth SA | -1.8% | -1.69% | Trim |
| 42 | OWLT | Owlet Inc | — | NEW | New buy |
| 43 | NEOG | Neogen CORP | — | NEW | New buy |
| 44 | PROF | Profound Medical CORP | — | NEW | New buy |
| 45 | VERI | Veritone Inc | — | NEW | New buy |
| 46 | CPSH | Cps Technologies CORP | — | NEW | New buy |
| 47 | BLNE | Beeline Holdings Inc | — | NEW | New buy |
| 48 | ✓ | — | NEW | New buy | |
| 49 | DGX | Quest Diagnostics Inc | — | EXIT | Sold out |
| 50 | XOM | Exxon Mobil CORP | — | NEW | New buy |
According to official SEC Form 13F filings, Perkins Capital Management Inc reported a total U.S. public equity portfolio value of $127.2M across 91 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NTRA, LLY, AXGN) accounted for 31.3% of total reported equity market value during Q4 2025.
Top New Position Initiated
OWLT
市值: $1.7M
Top Position Liquidated / Trimmed
DGX
前期市值: $228.7K
During Q4 2025, Perkins Capital Management Inc's top holdings by market value included NTRA (8.1%)、LLY (7.7%)、AXGN (5.9%). The largest single position, NTRA, represented 8.1% of total portfolio value.
In Q4 2025, Perkins Capital Management Inc made 48 total portfolio adjustments, initiating 8 new buys, adding to 12 positions, trimming 27 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.